Management of Achalasia: Expert Consensus Statements

A Reum Choe; Hye-Kyung Jung

doi:10.4166/kjg.2019.73.5.294

Journal List > Korean J Gastroenterol > v.73(5) > 1125187

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Choe and Jung: Management of Achalasia: Expert Consensus Statements

Brief Summary of Practice Guideline

The Korean Journal of Gastroenterology 2019; 73(5): 294-298.

Published online: 27 May 2019

DOI: https://doi.org/10.4166/kjg.2019.73.5.294

Management of Achalasia: Expert Consensus Statements

A Reum Choe, Hye-Kyung Jung

Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea.

Correspondence to: Hye-Kyung Jung, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul 07985, Korea. Tel: +82-2-2650-5205, Fax: +82-2-2655-2076, junghk@ewha.ac.kr

Received 21 April 2019 Revised 19 May 2019 Accepted 19 May 2019

Korean Society of Gastroenterology

(open-access):

This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Achalasia is a motility disorder of the esophagus characterized by absence of peristalsis and failure of relaxation of lower esophagus sphincter. The introduction of high resolution manometry (HRM) and per-oral endoscopic myotomy (POEM) has made a new chapter in diagnosis and treatment of achalasia. HRM allows classify according to the subtype of achalasia, and help predict prognosis and therapeutic response. POEM is a minimally invasive, effective option for treating achalasia. The management of achalasia required tailored application of various therapies such as botox injection, pneumatic balloon dilatation, POEM, or Heller's myotomy. In this review, we state the important aspects of diagnosis as well as management of achalasia.

Keywords: Esophageal achalasia, Manometry, Myotomy

Figures and Tables

Fig. 1

Achalasia subtypes according to Chicago classification in high resolution manometry. (A) Type I achalasia. (B) Type II achalasia. (C) Type III achalasia.

Notes

^{Financial support} None.

^{Conflict of interest} None.

References

1. Pandolfino JE, Kwiatek MA, Nealis T, Bulsiewicz W, Post J, Kahrilas PJ. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology. 2008; 135:1526–1533.

2. Ramchandani M, Nageshwar Reddy D, Nabi Z, et al. Management of achalasia cardia: expert consensus statements. J Gastroenterol Hepatol. 2018; 33:1436–1444.

3. Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015; 27:160–174.

4. Roman S, Zerbib F, Quenehervé L, Clermidy H, Varannes SB, Mion F. The Chicago classification for achalasia in a French multicentric cohort. Dig Liver Dis. 2012; 44:976–980.

5. Rohof WO, Salvador R, Annese V, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology. 2013; 144:718–725.

6. Schlottmann F, Luckett DJ, Fine J, Shaheen NJ, Patti MG. Laparoscopic Heller myotomy versus peroral endoscopic myotomy (POEM) for achalasia: a systematic review and metaanalysis. Ann Surg. 2018; 267:451–460.

7. Chan SM, Wu JC, Teoh AY, et al. Comparison of early outcomes and quality of life after laparoscopic Heller's cardiomyotomy to peroral endoscopic myotomy for treatment of achalasia. Dig Endosc. 2016; 28:27–32.

8. Docimo S Jr, Mathew A, Shope AJ, Winder JS, Haluck RS, Pauli EM. Reduced postoperative pain scores and narcotic use favor per-oral endoscopic myotomy over laparoscopic Heller myotomy. Surg Endosc. 2017; 31:795–800.

9. Khashab MA, Messallam AA, Onimaru M, et al. International multicenter experience with peroral endoscopic myotomy for the treatment of spastic esophageal disorders refractory to medical therapy (with video). Gastrointest Endosc. 2015; 81:1170–1177.

10. Khan MA, Kumbhari V, Ngamruengphong S, et al. Is POEM the answer for management of spastic esophageal disorders? A systematic review and meta-analysis. Dig Dis Sci. 2017; 62:35–44.

11. Zaninotto G, Annese V, Costantini M, et al. Randomized controlled trial of botulinum toxin versus laparoscopic Heller myotomy for esophageal achalasia. Ann Surg. 2004; 239:364–370.

12. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial. Ann Intern Med. 1994; 121:590–591.

13. Bassotti G, Annese V. Review article: pharmacological options in achalasia. Aliment Pharmacol Ther. 1999; 13:1391–1396.

14. Ghoshal UC, Rangan M. A review of factors predicting outcome of pneumatic dilation in patients with achalasia cardia. J Neurogastroenterol Motil. 2011; 17:9–13.

15. Zaninotto G, Costantini M, Portale G, et al. Etiology, diagnosis, and treatment of failures after laparoscopic Heller myotomy for achalasia. Ann Surg. 2002; 235:186–192.

16. Ellis FG. The natural history of achalasia of the cardia. Proc R Soc Med. 1960; 53:663–666.

17. Inoue H, Shiwaku H, Iwakiri K, et al. Clinical practice guidelines for peroral endoscopic myotomy. Dig Endosc. 2018; 30:563–579.

18. Duranceau A, Liberman M, Martin J, Ferraro P. End-stage achalasia. Dis Esophagus. 2012; 25:319–330.

19. Neyaz Z, Gupta M, Ghoshal UC. How to perform and interpret timed barium esophagogram. J Neurogastroenterol Motil. 2013; 19:251–256.

20. Ghoshal UC, Kumar S, Saraswat VA, Aggarwal R, Misra A, Choudhuri G. Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence. Am J Gastroenterol. 2004; 99:2304–2310.

21. Eckardt VF, Gockel I, Bernhard G. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut. 2004; 53:629–633.

TOOLS

ORCID iDs: Hye-Kyung Jung
https://orcid.org/0000-0002-6653-5214
Similar articles